Burcon Nutrascience (TSE:BU) has released an update.
Burcon NutraScience Corporation reports a pivotal fiscal Q1 with its first direct commercial protein sale, marking a transition from technology development to profit generation. The company’s capital-light strategy and new revenue streams, including high purity hempseed and canola protein sales, are set to deliver increased shareholder value. Burcon is also expanding its market reach with the launch of its products on the OTCQB Venture Market and the appointment of a new CFO.
For further insights into TSE:BU stock, check out TipRanks’ Stock Analysis page.
